Benzinga - Fri, 05 Mar 2021 13:47:47 -0400
Benzinga - Thu, 04 Mar 2021 08:01:05 -0400
Benzinga - Fri, 19 Feb 2021 10:51:16 -0400
Benzinga - Thu, 18 Feb 2021 08:28:36 -0400
Benzinga - Thu, 18 Feb 2021 06:07:42 -0400
Benzinga - Mon, 25 Jan 2021 05:57:01 -0400
Benzinga - Fri, 22 Jan 2021 13:32:54 -0400
Benzinga - Fri, 15 Jan 2021 17:42:01 -0400
Benzinga - Tue, 08 Dec 2020 17:44:30 -0400
Benzinga - Tue, 08 Dec 2020 05:55:42 -0400
Benzinga - Mon, 07 Dec 2020 13:02:48 -0400
load more
Sector: Health Care.Industry: Pharmaceuticals
Auris Medical Holding Ltd is a clinical-stage biopharmaceutical company. The company develops novel products for the treatment of inner ear disorders. It has two projects in advanced clinical development Keyzilen for the treatment of acute inner ear tinnitus and AM-111 for the treatment of acute inner ear hearing loss. It is developing Keyzilen for the treatment of acute inner ear (peripheral) tinnitus following traumatic cochlear injury or otitis media (middle ear infection). Keyzilen contains Esketamine hydrochloride, an N-Methyl-D-Aspartate (NMDA) receptor antagonist, formulated in a biocompatible and fully biodegradable gel. It is also developing AM-111 for the treatment of acute inner ear (sensorineural) hearing loss (ASNHL).

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Related Companies

TickerCompanyChg %Mkt Cap
EARSAuris Medical Holding12.46%36.1M

Auris Medical Holding Company Questions & Answers

Q

How do I buy Auris Medical Holding (EARS) stock?

A

You can purchase shares of Auris Medical Holding (NASDAQ: EARS) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Auris Medical Holding's (EARS) main competitors?

A

Other companies in Auris Medical Holding’s space includes: Teligent (NASDAQ:TLGT), Cumberland (NASDAQ:CPIX) and Titan Pharmaceuticals (NASDAQ:TTNP).

Q

What is the target price for Auris Medical Holding?

A

The latest price target for Auris Medical Holding (NASDAQ: EARS) was reported by Roth Capital on 2017-04-13. The analyst firm set a price target for 0.00 expecting EARS to fall to within 12 months (a possible -100.00% downside). 0 analyst firms have reported ratings in the last year.

Q

How much is Auris Medical Holding (EARS) stock ?

A

The stock price for Auris Medical Holding (NASDAQ: EARS) is $3.16 last updated Fri Mar 05 2021 21:00:02 GMT+0000 (Coordinated Universal Time).

Q

When is the next Auris Medical Holding (EARS) dividend?

A

There are no upcoming dividends for Auris Medical Holding.

Q

When is Auris Medical Holding (NASDAQ:EARS) reporting earnings?

A

There are no earnings for Auris Medical Holding

Q

When is the upcoming split for EARS?

A

There is no upcoming split for Auris Medical Holding.